Clinical studies on growth factors in pressure sores

preliminary report.

M. C. Robson, Linda Phillips, J. P. Heggers, M. A. McPherson, L. S. Heiner

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Agents touted to benefit chronic non-healing wounds will become evermore prevalent. Examples, in addition to those cited, might include epictor (EGF) or platelet derived growth factor (PDGF). Although they may look promising in in vitro and experimental animal studies, they must be tested in humans. The pressure sore is a chronic three dimensional wound which lends itself to study of wound healing agents. It has been used for severe such trials and appears to be an excellent model for the continued study of peptide growth factors.

Original languageEnglish (US)
Pages (from-to)95-102
Number of pages8
JournalProgress in Clinical and Biological Research
Volume365
StatePublished - 1991

Fingerprint

Pressure Ulcer
Intercellular Signaling Peptides and Proteins
Platelet-Derived Growth Factor
Wounds and Injuries
Epidermal Growth Factor
Wound Healing
Peptides
Clinical Studies
In Vitro Techniques

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Robson, M. C., Phillips, L., Heggers, J. P., McPherson, M. A., & Heiner, L. S. (1991). Clinical studies on growth factors in pressure sores: preliminary report. Progress in Clinical and Biological Research, 365, 95-102.

Clinical studies on growth factors in pressure sores : preliminary report. / Robson, M. C.; Phillips, Linda; Heggers, J. P.; McPherson, M. A.; Heiner, L. S.

In: Progress in Clinical and Biological Research, Vol. 365, 1991, p. 95-102.

Research output: Contribution to journalArticle

Robson, M. C. ; Phillips, Linda ; Heggers, J. P. ; McPherson, M. A. ; Heiner, L. S. / Clinical studies on growth factors in pressure sores : preliminary report. In: Progress in Clinical and Biological Research. 1991 ; Vol. 365. pp. 95-102.
@article{c5fab3986b874e4b91d85d1081fee327,
title = "Clinical studies on growth factors in pressure sores: preliminary report.",
abstract = "Agents touted to benefit chronic non-healing wounds will become evermore prevalent. Examples, in addition to those cited, might include epictor (EGF) or platelet derived growth factor (PDGF). Although they may look promising in in vitro and experimental animal studies, they must be tested in humans. The pressure sore is a chronic three dimensional wound which lends itself to study of wound healing agents. It has been used for severe such trials and appears to be an excellent model for the continued study of peptide growth factors.",
author = "Robson, {M. C.} and Linda Phillips and Heggers, {J. P.} and McPherson, {M. A.} and Heiner, {L. S.}",
year = "1991",
language = "English (US)",
volume = "365",
pages = "95--102",
journal = "Progress in Clinical and Biological Research",
issn = "0361-7742",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Clinical studies on growth factors in pressure sores

T2 - preliminary report.

AU - Robson, M. C.

AU - Phillips, Linda

AU - Heggers, J. P.

AU - McPherson, M. A.

AU - Heiner, L. S.

PY - 1991

Y1 - 1991

N2 - Agents touted to benefit chronic non-healing wounds will become evermore prevalent. Examples, in addition to those cited, might include epictor (EGF) or platelet derived growth factor (PDGF). Although they may look promising in in vitro and experimental animal studies, they must be tested in humans. The pressure sore is a chronic three dimensional wound which lends itself to study of wound healing agents. It has been used for severe such trials and appears to be an excellent model for the continued study of peptide growth factors.

AB - Agents touted to benefit chronic non-healing wounds will become evermore prevalent. Examples, in addition to those cited, might include epictor (EGF) or platelet derived growth factor (PDGF). Although they may look promising in in vitro and experimental animal studies, they must be tested in humans. The pressure sore is a chronic three dimensional wound which lends itself to study of wound healing agents. It has been used for severe such trials and appears to be an excellent model for the continued study of peptide growth factors.

UR - http://www.scopus.com/inward/record.url?scp=0025931116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025931116&partnerID=8YFLogxK

M3 - Article

VL - 365

SP - 95

EP - 102

JO - Progress in Clinical and Biological Research

JF - Progress in Clinical and Biological Research

SN - 0361-7742

ER -